Gabapentin Capsule
Product Images NDC 80425-0128
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin 100mg Cap Qty 90 Ndc 80425 0128
Structure
Image 0
This appears to be a formula for calculating "Lt" (likely referring to something medical-related) using a patient's age and weight. It also mentions the value for creatinine for female patients. However, without more context or information, it is difficult to provide a more specific or useful description.*
Image 1
This appears to be the presentation of data related to a clinical trial. It includes information on the dosing schedule, treatment groups (placebo vs Gatspntin), and mean pain scores at baseline and during multiple time points in the study. However, without additional context or information on the study design and objectives, it is difficult to provide a more detailed description of the data.*
Image 3
This is a graph labeled as "Figure 3" that displays the proportion of responders, which are patients with more than 50% reduction in pain score, in controlled PHN studies. The graph compares three different treatment groups (PBO, GBP 3600, and GBP 1800/2400) across two studies (Study 1 and Study 2). The y-axis goes from 0% to 100%, and the x-axis depicts the treatment groups and studies.*
Image0
This appears to be a chart or graph related to pain scores and medication dosages. It shows two four-week periods, one with a fixed dosage and the other with a medication called Gabapentin. The pain score starts at 0 and does not increase throughout the duration of both periods. However, without further context or explanation, it is not possible to provide a more detailed description or analysis.*
Image4
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.